# Advisor Review - GPT-5-mini

**Role:** Academic advisor checking for fatal errors
**Model:** openai/gpt-5-mini
**Paper:** paper.pdf
**Timestamp:** 2026-02-01T19:03:03.982408
**Route:** OpenRouter + LaTeX
**Tokens:** 17628 in / 1189 out
**Response SHA256:** c8a79a57428f7563

---

I reviewed the draft for fatal errors in the four mandated categories (Data-Design Alignment, Regression Sanity, Completeness, Internal Consistency). I found no issues that meet your definition of a fatal error.

Summary of checks performed and findings (brief):

- Data-design alignment
  - Treatment timing vs data coverage: 2010 Census population → eligibility effective ~FY2012; outcomes measured in 2016–2020 ACS. Timing is internally consistent (max treatment year ≤ outcome years). The paper consistently defines treatment as Section 5307 eligibility on 2010 population ≥50,000.
  - Post-treatment observations: Outcomes are measured 4–8 (or 6–10) years after eligibility—there are post-treatment observations for cohorts as described.
  - Treatment definition consistency: Treatment is defined uniformly as D_i = 1[X_i ≥ 0] using 2010 population; Table and text definitions match.

- Regression sanity
  - Standard errors and coefficients: All reported coefficients and robust SEs are of plausible magnitude for the outcomes (e.g., transit share estimate −0.0015 with SE 0.0043). No SEs or coefficients violate the numerical thresholds you specified (e.g., SEs >> 1000, |coef| > 100, R² out of [0,1], negative SEs, Inf/NaN). No obviously impossible values appear in any table.
  - No instances of extremely large SEs or coefficients that would indicate collinearity artifacts are present in the tables and appendix.

- Completeness
  - No placeholder text such as NA/TBD/XXX appears in tables or figures. Regression tables include robust SEs and p-values. Sample sizes (total N and side-specific numbers) are reported in main and appendix tables/notes. Figures referenced in the text (e.g., distribution, RD plots, placebo tests) are included.
  - Methods described match the reported analyses: bandwidth sensitivity, kernel/polynomial robustness, manipulation tests, placebo thresholds are reported.

- Internal consistency
  - Numbers cited in text (sample sizes, point estimates, SEs, CIs, p-values) are consistent with the corresponding tables and figures (e.g., abstract/main text transit estimate and CI match Table 1 and Figure notes).
  - Treatment timing, sample period, and running variable definition are consistent across sections.
  - Column and figure labels match the described specifications (kernels, bandwidth mults, etc.). Reported robustness checks and their outcomes are present and coherent.

Therefore there are zero fatal errors under the criteria you specified.

ADVISOR VERDICT: PASS